| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/23/2004 | US20040184999 Delivery of anti-migraine compounds through an inhalation route |
| 09/23/2004 | US20040184998 Delivery of drug esters through an inhalation route |
| 09/23/2004 | US20040184997 volatilizing a coating of drug on a solid support, having the surface texture of a metal foil, to a temperature sufficient to produce a heated vapor of drug and condensing the heated vapor to form condensation aerosol particles |
| 09/23/2004 | US20040184996 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 09/23/2004 | US20040184995 coating a fine biologically active substance in crystal form with a specific electrostatic aggregation-inhibiting substance, particle diameter of 0.5 to 8 mu m |
| 09/23/2004 | US20040184994 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
| 09/23/2004 | US20040184993 allows the modulation of the mass median aerodynamic diameter of the aerosol particles on actuation of the inhaler to a value which is suited for the pulmonary administration |
| 09/23/2004 | US20040184992 Mousse composition |
| 09/23/2004 | US20040182704 For use in actuating or drug delivery devices containing an artificial muscle valve and micropump that controls the release of therapeutic fluids including implantable platforms |
| 09/23/2004 | US20040182383 Method for treating diabetes mellitus in a patient |
| 09/23/2004 | US20040182283 Pearlescent film coating systems and substrates coated therewith |
| 09/23/2004 | DE202004010021U1 Chewing composition for oral administration, e.g. sweet or gum, used for treating vitamin deficiency or as vitamin supplement, contains solubilized fat-soluble vitamin(s) and optionally vehicle and additives |
| 09/23/2004 | DE10309473A1 Feste, exakt dosierbare pharmazeutische Darreichungsformen zur Einzelausgabe aus Dosiervorrichtungen Festivals, exactly dosed pharmaceutical dosage forms for single output from metering |
| 09/23/2004 | CA2522818A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | CA2519070A1 Dry polymer and lipid composition |
| 09/23/2004 | CA2518883A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | CA2518780A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 09/23/2004 | CA2518393A1 Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid |
| 09/23/2004 | CA2518385A1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine |
| 09/23/2004 | CA2518329A1 Rapidly absorbing lipophilic skin compositions and uses therefor |
| 09/23/2004 | CA2518275A1 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | CA2518216A1 Oral insulin therapies and protocol |
| 09/23/2004 | CA2518200A1 Impregnated powder improving bioavailability and/or solubility and method of production |
| 09/23/2004 | CA2517853A1 Polymer compositions with bioactive silver, copper or zinc compounds, medical articles, and processes |
| 09/23/2004 | CA2517778A1 Extended transdermal contraceptive regimens |
| 09/23/2004 | CA2516338A1 Novel compositions containing fentanyl |
| 09/22/2004 | EP1460423A1 Three-dimensional colorimetric assay assemblies |
| 09/22/2004 | EP1460120A1 Anion generating material and skin treating agent using the same |
| 09/22/2004 | EP1460089A1 Controlled release of antimicrobial substances from polymer matrices |
| 09/22/2004 | EP1460080A1 Direct compressible trehalose solids |
| 09/22/2004 | EP1460060A1 Method of obtaining novel lutein-based formulations |
| 09/22/2004 | EP1459782A2 Method and device for targeted epithelial delivery of medicinal and related agents |
| 09/22/2004 | EP1459767A1 Hard capsules |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459743A2 Agent for prophylaxis and treatment of glaucoma |
| 09/22/2004 | EP1459742A2 Agent for prophylaxis and treatment of asthenopia and pseudomyopia |
| 09/22/2004 | EP1459741A1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with menthylphenidate |
| 09/22/2004 | EP1459740A1 Compositions containing sucralose |
| 09/22/2004 | EP1459739A1 Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids |
| 09/22/2004 | EP1459738A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 09/22/2004 | EP1459737A1 Granules containing acid-unstable chemical in large amount |
| 09/22/2004 | EP1458806A1 Heteroxylan film-forming composition for making capsules and resulting capsules |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458468A2 Granules obtained by drying an emulsion comprising a polymer and a monosaccharide or a monosaccharide derivative |
| 09/22/2004 | EP1458435A2 Medication delivery system and monitor |
| 09/22/2004 | EP1458427A2 Compositions comprising collagen and metalloprotease inhibitors |
| 09/22/2004 | EP1458425A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |
| 09/22/2004 | EP1458421A1 Composition for treating contact lenses in the eye |
| 09/22/2004 | EP1458420A2 Composition for treating contact lenses |
| 09/22/2004 | EP1458413A2 Pharmaceutical compositions based on azetidine derivatives |
| 09/22/2004 | EP1458408A1 Liquid composition of factor vii polypeptides |
| 09/22/2004 | EP1458402A1 Improvements in or relating to liquid, eye-instillable preparations comprising sodium hyaluronate |
| 09/22/2004 | EP1458401A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 09/22/2004 | EP1458400A1 Liquid bisphosphonate formulations for bone disorders |
| 09/22/2004 | EP1458398A1 Antibiotic formulation and a method of making this formulation |
| 09/22/2004 | EP1458388A1 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity |
| 09/22/2004 | EP1458387A2 Orodispersible tablets containing fexofenadine |
| 09/22/2004 | EP1458384A1 Amlopidine bezylate tablets with improved stability |
| 09/22/2004 | EP1458377A1 5ht4 partial agonist pharmaceutical compositions |
| 09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
| 09/22/2004 | EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine |
| 09/22/2004 | EP1458369A1 Gel comprising at least a retinoid and benzoyl peroxide |
| 09/22/2004 | EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 09/22/2004 | EP1458366A1 Adhesive transdermal formulations of diclofenac sodium |
| 09/22/2004 | EP1458365A1 Improved polymer-lipid delivery vehicles |
| 09/22/2004 | EP1458364A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 09/22/2004 | EP1458363A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458361A2 Compositions for sustained action product delivery |
| 09/22/2004 | EP1458360A1 Pulmonary delivery of aminoglycosides |
| 09/22/2004 | EP1458359A1 Microemulsion preconcentrate |
| 09/22/2004 | EP1458358A1 Stable topical formulation of clarithromycin |
| 09/22/2004 | EP1458357A2 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 09/22/2004 | EP1458356A1 Micronized pharmaceutical or nutraceutical powder with immediate release |
| 09/22/2004 | EP1458355A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 09/22/2004 | EP1458354A1 Medicinal aerosol formulations comprising ion pair complexes |
| 09/22/2004 | EP1458353A1 Formulation dosage form for the controlled delivery of ther apeutic agents |
| 09/22/2004 | EP1458352A1 Solid dose micro implant |
| 09/22/2004 | EP1458337A1 Stable surfactant compositions for suspending components |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458246A1 Process for preparing chewing gum containing a nutritional supplement |
| 09/22/2004 | EP1458228A2 Cultivated agarwood |
| 09/22/2004 | EP1408876A4 Zero-order prolonged release coaxial implants |
| 09/22/2004 | EP1301238B1 Needles coated with vaccine |
| 09/22/2004 | EP1289505B1 Process of producing a stable pharmaceutical composition containing micronized formoterol |
| 09/22/2004 | EP1242073B1 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/22/2004 | EP1242047B1 Fenofibrate galenic formulations and method for obtaining same |
| 09/22/2004 | EP1235835A4 Chromium-histidine complexes as nutrient supplements |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1207859B1 Oral form of administration containing probiotic micro-organisms |
| 09/22/2004 | EP1196144B1 A liposome composition having resistance to freeze/thaw damage |
| 09/22/2004 | EP1152743B1 Skin sanitizing compositions |
| 09/22/2004 | EP1100407A4 Composition for freshening nostrils and sinus cavities |
| 09/22/2004 | EP1098646B1 Stabilized carvedilol injection solution |
| 09/22/2004 | EP1069888B1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 09/22/2004 | EP1064950B1 Remedies for hepatitis |
| 09/22/2004 | EP1001750B1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 09/22/2004 | EP0998273B1 Osmotic delivery system flow modulator apparatus |
| 09/22/2004 | EP0987954B1 A spinner head having flow restricting inserts |
| 09/22/2004 | EP0941121B1 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |